SEARCH RESULTS FOR: "Tag: ecyt"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2018(5)
CATEGORIES
Buzz Stocks(1)
Opening View(1)
Quantitative Analysis(2)
Stocks On the Move(1)
Technical Analysis(2)

10/18/2018 10:29 AM
Switzerland's Novartis AG (NYSE:NVS) said it will pay $2.1 bllion in cash for Endocyte (ECYT) -- or $24 per ECYT share -- hoping to capitalize on the Indiana-based drugmaker's prostrate cancer treat...
10/18/2018 9:10 AM
Dow Jones Industrial Average (DJIA) futures are trading below fair value this morning, with focus staying on yesterday's release of the Fed meeting minutes. Earnings also continue to roll through, ...
9/20/2018 2:34 PM
Endocyte, Inc. (NASDAQ:ECYT) stock is up 1% at $17.71 in afternoon trading -- and if past is prologue, the biopharmaceutical concern could be headed even higher soon. Below we will dig deeper into t...
9/10/2018 2:51 PM
The U.S. stock market is mixed this afternoon, with blue chips lagging. Among individual names making big moves are electric carmaker Tesla Inc (NASDAQ:TSLA), cloud concern Akamai Technologies, Inc...
7/20/2018 11:56 AM
Shares of Endocyte, Inc. (NASDAQ:ECYT) are trading higher this afternoon, last seen up 0.1% at $17.12. This is just more of the same for ECYT, which bounced from reliable support at its 40-day moving...
PEOPLE ALSO SEARCH FOR

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center